Non-COVID-19-Related Deaths Up, Too
Excess deaths seen for specific gender and age groups, with protective effect seen for female children
Chimpanzee Adenovirus COVID-19 Vaccine Promising in Seniors
Immunogenicity similar across age groups; vaccine better tolerated in older versus younger adults
WHO: Remdesivir Not Advised for Hospitalized COVID-19 Patients
Evidence to date has not shown clinically important effects on mortality, need for mechanical ventilation
Third COVID-19 Vaccine Shows Effectiveness
The AstraZeneca vaccine becomes the third to show good effectiveness
AHA: Blacks, Hispanics Make Up 53 Percent of COVID-19 Deaths
Mortality, MACE rates among patients hospitalized with COVID-19 did not differ by race, ethnicity
Early ECMO-Facilitated Resuscitation Ups Survival in OHCA
Findings seen among adults with out-of-hospital cardiac arrest and refractory ventricular fibrillation
FDA Authorizes Use of Monoclonal Antibody Treatment for COVID-19
IV infusion of casirivimab and imdevimab authorized for treatment of mild-to-moderate COVID-19
Predictors of Late Effects in Young AML Survivors Explored
Most common late effects were endocrine, cardiovascular, respiratory; likelihood of late effects up for those who underwent HSCT
Rates of VTE, Major Bleeding High in Primary CNS Lymphoma
Pulmonary embolism and major bleeding linked to increased mortality risk
FDA Issues EUA to Baricitinib Plus Remdesivir for COVID-19
Emergency use authorization applies to hospitalized patients requiring supplemental oxygen, mechanical ventilation, ECMO
